Mathieu Charvériat

View articles by Mathieu Charvériat

Lettre aux Actionnaires

Lettre aux Actionnaires

January 9, 2025

65 likes2 comments

Theranexus joins up with Synerlab to prepare the commercialization of its pediatric formulation in Niemann-Pick type C disease

Theranexus joins up with Synerlab to prepare…

October 17, 2024

144 likes6 comments

Final and positive safety and efficacy data in the Phase I/II trial testing Batten-1

Final and positive safety and efficacy data…

April 18, 2024

92 likes3 comments

Encouraging preliminary 6-month results in the Phase I/II trial of Batten-1 in Batten disease (CLN3)

Encouraging preliminary 6-month results in…

June 14, 2023

32 likes

Organizing a Methods Collection titled “Current methods to study neuroglial interactions in physiological and pathological conditions”

Organizing a Methods Collection titled…

July 21, 2020

30 likes1 comment

Theranexus a reçu la visite de Madame Florence Parly, ministre des Armées

Theranexus a reçu la visite de Madame…

October 3, 2018

60 likes3 comments

Theranexus presents new data on the stimulating effect of its drug candidate THN102

Theranexus presents new data on the…

July 5, 2018

17 likes

Chef de projet études cliniques senior (H/F)

Chef de projet études cliniques senior (H/F)

October 26, 2017

19 likes

Nous recherchons un(e) Chargé(e) d'études cliniques (H/F)

Nous recherchons un(e) Chargé(e) d'études…

September 10, 2016

11 likes

翻译：